> Aeterna Zentaris ($AEZS) picked CRO Ergomed to help run a Phase III trial of its macimorelin, designed to treat adult growth hormone deficiency. More
> The FDA has overhauled its Risk Evaluation and Mitigation Strategies (REMS) website to make it easier to find up-to-date information. News